Improvement of clofibrate dissolution by complexation with cyclodextrin

International Journal of Pharmaceutics

Volumn 135, Issue 1-2, 1996, Pages 161-166

  Anguiano Igea, S ^a   Otero Espinar, F J ^a   Vila Jato, J L ^a   Blanco Mendez J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Clofibrate; Coprecipitation; Cyclodextrin; Inclusion complexation; Kneading; Sealed heating; Solid form; Solubility

Indexed keywords

CLOFIBRATE; CYCLODEXTRIN;

ARTICLE; COMPLEX FORMATION; DRUG SCREENING; DRUG SOLUBILITY; PRECIPITATION; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 0030591415     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04477-8     Document Type: Article

References (13)

1. Anguiano-Igea, S., Otero-Espinar, F.J., Vila-Jato, J.L. and Blanco-Méndez, J., Evaluation of sealed heating method for the obtention of a clofibrate-β-cyclodextrin inclusion complex. Stp Pharma Sci., 2 (1992) 325-331.
2. Anguiano-Igea, S., Otero-Espinar, F.J., Vila-Jato, J.L. and Blanco-Méndez J., Rheological properties of the complex clofibrate/β-cyclodextrin. Proc. Intern. Symp. Control Rel. Bioact. Mater., 21 (1994) 728-729.
3. 1H-NMR and molecular modelling studies. Eur. J. Pharm. Sci., (1996) submitted for publication.
4. Ben-Amor, A.-F., Avantages et limites des procédés galéniques destinés à améliorer la biodisponibilité d'un principe actif peu soluble et administré par voie orale: le fénofibrate. Ph.D. thesis. University of Ginebra (1990).
5. Blanco, J., Vila-Jato, J.E., Otero, F.J. and Anguiano, S., Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins. Drug Dev. Ind. Pharm., 17 (1991) 943-957.
6. Fucile, M.G., Mazzitelli, G., Ratti, D. and Pozzi, F., Inclusion complex of isosorbide-5-mononitrate in β-cyclodextrin: comparison of preparation methods and assessment of analytical techniques. Eur. J. Pharm. Biopharm., 38 (1992) 140-144.
7. Hassan, M.M.A. and Elazzouny, A.A., Clofibrate. In: Florey, K. (Ed.), Analytical Profiles of Drug Substances, Vol. 11, Academic Press, New York, 1982, pp. 197-224.
8. Khan, C.A. and Rhodes, C.T., The concept of dissolution efficiency. J. Pharm. Pharmacol., 27 (1975) 48-49.
9. Nakai, Y., Yamamoto, K., Oguchi, T., Saito, H., Yonemochi, E. and Hanawa, T., New methods for preparing cyclodextrin inclusion compounds III. Preparation of heptakis-(2,6-di-O-methyl)-β-cyclodextrin-benzoic acid inclusion compound by sealed heating. Chem. Pharm. Bull., 38 (1990) 1345-1348.
10. Nakai, Y., Yamamoto, K., Terada, K., Oguchi, T., Saito. H. and Watanabe, D., New methods for preparing cyclodextrin inclusion compounds II. Effects of heating temperature, water content and drug properties on the inclusion formation. Chem. Pharm. Bull, 37 (1989) 1055-1058.
11. Nakai, Y., Yamamoto, K., Terada, K. and Watanabe, D., New methods for preparing cyclodextrin inclusion compounds I. Heating in a sealed container. Chem. Pharm. Bull., 35 (1987) 4609-4615.
12. The Merck Index., Budavari, S., (Ed.). Merck and Co. Inc., 1989, p. 2376.
13. Uekaraa, K., Oh, K., Otagiri, M., Seo, H. and Tsuruoka, M., Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation. Pharm. Acta Helv., 58 (1983) 338-342.